WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lexicon Pharmaceuticals earnings were -$177.3M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LXRX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$25.3M, down 25.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LXRX reported annual earnings of -$200.4M, with 13.1% growth.

LXRX earnings history

Current Revenue
$31.2M
Current Earnings
-$177.3M
Current Profit Margin
-568%

LXRX Return on Equity

Current Company
-103.2%
Current Industry
-60.2%
Current Market
31.5%
LXRX's Return on Equity (-103.2%)... subscribe to Premium to read more.
High Return on Equity Performance

LXRX undefined

Current Company
-55%
Current Industry
-2.5%
LXRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LXRX announces earnings.

LXRX undefined

Current Company
-88.16%
Current Industry
5.8%
LXRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LXRX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LXRX-$164.27M-$177.30MN/A-$0.51
THRD-$52.65M-$53.45MN/A-$1.23
PROK-$62.60M-$68.43MN/A-$0.60
FHTX-$71.61M-$80.44MN/A-$1.36
DBVT-$113.67M-$113.65MN/A-$5.70
View Top Biotech Stocks

Lexicon Pharmaceuticals Earnings Reports & History FAQ

What were Lexicon Pharmaceuticals's earnings last quarter?

On LXRX's earnings call on Invalid Date, Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q1 2025 earnings per share (EPS) of -$0.07, up 65% year over year. Total LXRX earnings for the quarter were -$25.30 million. In the same quarter last year, Lexicon Pharmaceuticals's earnings per share (EPS) was -$0.20.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.

Is Lexicon Pharmaceuticals profitable or losing money?

As of the last Lexicon Pharmaceuticals earnings report, Lexicon Pharmaceuticals is currently losing money. Lexicon Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$177.30 million, a 8.41% decrease year over year.

What was LXRX's earnings growth in the past year?

As of Lexicon Pharmaceuticals's earnings date in Invalid Date, Lexicon Pharmaceuticals's earnings has grown year over year. LXRX earnings in the past year totalled -$177.30 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.